GeneDx Total Operating Expenses from 2010 to 2025
| WGSWW Stock | 0.16 0.01 5.88% |
Total Operating Expenses | First Reported 2010-12-31 | Previous Quarter 214.2 M | Current Value 304 M | Quarterly Volatility 113.1 M |
Check GeneDx Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among GeneDx Holdings' main balance sheet or income statement drivers, such as Interest Income of 3.1 M, Depreciation And Amortization of 31.3 M or Interest Expense of 2.7 M, as well as many indicators such as Price To Sales Ratio of 3.98, Dividend Yield of 0.0 or PTB Ratio of 8.85. GeneDx financial statements analysis is a perfect complement when working with GeneDx Holdings Valuation or Volatility modules.
GeneDx | Total Operating Expenses |
Latest GeneDx Holdings' Total Operating Expenses Growth Pattern
Below is the plot of the Total Operating Expenses of GeneDx Holdings Corp over the last few years. It is the total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses. GeneDx Holdings' Total Operating Expenses historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in GeneDx Holdings' overall financial position and show how it may be relating to other accounts over time.
| Total Operating Expenses | 10 Years Trend |
|
Total Operating Expenses |
| Timeline |
GeneDx Total Operating Expenses Regression Statistics
| Arithmetic Mean | 186,297,457 | |
| Geometric Mean | 162,205,592 | |
| Coefficient Of Variation | 60.73 | |
| Mean Deviation | 91,374,322 | |
| Median | 113,198,000 | |
| Standard Deviation | 113,137,387 | |
| Sample Variance | 12800.1T | |
| Range | 317.6M | |
| R-Value | 0.69 | |
| Mean Square Error | 7204.5T | |
| R-Squared | 0.47 | |
| Significance | 0 | |
| Slope | 16,372,279 | |
| Total Sum of Squares | 192001T |
GeneDx Total Operating Expenses History
About GeneDx Holdings Financial Statements
GeneDx Holdings investors use historical fundamental indicators, such as GeneDx Holdings' Total Operating Expenses, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in GeneDx Holdings. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Total Operating Expenses | 214.2 M | 304 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Additional Tools for GeneDx Stock Analysis
When running GeneDx Holdings' price analysis, check to measure GeneDx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneDx Holdings is operating at the current time. Most of GeneDx Holdings' value examination focuses on studying past and present price action to predict the probability of GeneDx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneDx Holdings' price. Additionally, you may evaluate how the addition of GeneDx Holdings to your portfolios can decrease your overall portfolio volatility.